Volume 64, Issue 2 pp. 343-345
Brief Report

Risk factors and treatment for steroid-related mood and behavior symptoms in preschool children with leukemia: A case series

Chase Samsel

Corresponding Author

Chase Samsel

Department of Psychiatry, Boston Children's Hospital, Boston, Massachusetts

Department of Psychosocial Oncology and Palliative Care, Dana–Farber Cancer Institute, Boston, Massachusetts

Harvard Medical School, Boston, Massachusetts

Correspondence

Chase Samsel, MD, Department of Psychosocial Oncology and Palliative Care, Dana–Farber Cancer Institute, SW360A, 450 Brookline Ave., Boston, MA 02115.

Email: [email protected]

Search for more papers by this author
Anna C. Muriel

Anna C. Muriel

Department of Psychiatry, Boston Children's Hospital, Boston, Massachusetts

Department of Psychosocial Oncology and Palliative Care, Dana–Farber Cancer Institute, Boston, Massachusetts

Harvard Medical School, Boston, Massachusetts

Search for more papers by this author
First published: 12 September 2016
Citations: 7

Abstract

Treatment of pediatric acute lymphoblastic leukemia (ALL) relies on systemic corticosteroids for remission; however, they can cause significant mood and behavior changes that interfere with quality of life and may increase risk for injury. This case series reports on preschool children with preexisting developmental and psychiatric risk factors who presented with behavioral side effects that required intervention. Identification of these vulnerable children may provide opportunities for early intervention, anticipatory guidance, and effective treatment to minimize behavioral side effects and improve quality of life and safety during ALL treatment.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.